XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Details) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Stockholders' Equity (Details) [Line Items]      
Total unrecognized compensation expense $ 231,362    
Weighted average period 2 years 3 days    
Aggregate intrinsic value of stock options, outstanding $ 20,430 $ 12,980  
Aggregate intrinsic value of stock options, exercisable $ 19,867 12,980  
Purchase an aggregate of common stock (in Shares) 24,000    
Exercise price of common stock (in Dollars per share) $ 1.94    
Purchase an aggregate of shares to common stock (in Shares) 25,000    
Exercise price (in Dollars per share) $ 1.94    
Aggregate fair value of options granted $ 90,380 $ 636,957  
Common stock outstanding $ 1,750,000    
Common stock, treasury shares (in Shares) 641,963   636,771
Repurchased shares of common stock $ 5,192    
Purchase price per share (in Dollars per share) $ 1.39    
2011 Plan [Member]      
Stockholders' Equity (Details) [Line Items]      
Number of shares issued under plan (in Shares) 28,964    
2016 Plan [Member]      
Stockholders' Equity (Details) [Line Items]      
Number of shares issued under plan (in Shares) 1,300,000    
Percentage of common stock delivered pursuant to incentive stock options 100.00%    
Number of stock available for future issuance (in Shares) 766,020